Mayr B, Pötter E, Goretzki P, Rüschoff J, Dietmaier W, Hoang-Vu C, Dralle H, Brabant G
Abteilung Klinische Endokrinologie, Medizinische Hochschule Hannover, Germany.
Br J Cancer. 1998 Mar;77(6):903-6. doi: 10.1038/bjc.1998.149.
Ret/PTC oncogene has been described with a frequency of 2.5-30% in papillary thyroid carcinomas. We examined the expression of ret/PTC in 99 German papillary thyroid carcinomas, including two recently described new variants of ret/PTC3 and identified eight ret/PTC-positive tumours (8%) but none with the new variants.
在甲状腺乳头状癌中,Ret/PTC癌基因的检出频率为2.5% - 30%。我们检测了99例德国甲状腺乳头状癌中Ret/PTC的表达情况,其中包括最近描述的Ret/PTC3的两种新变体,结果发现8例Ret/PTC阳性肿瘤(8%),但均未发现新变体。